EPB41L4A-DT

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, EPB41L4A-DT RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated EPB41L4A-DT data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher EPB41L4A-DT RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated EPB41L4A-DT expression acts as an unfavorable survival marker, although some lineages such as KIRC and KIRP show a favorable association.

KIRC, KIRP, and HNSC are the cancer types where EPB41L4A-DT RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCDFSMedianAll0.7530.501<.001161view →
KIRPOSTertileAll0.8830.563<.001103view →
HNSCDFSQuartileAll0.7130.488<.00198view →
MESOOSQuartileAll0.7750.381<.00180view →
LUADOSQuartileII,III,IV0.9640.626<.00151view →
KICHOSMedianIII,IV1.0000.733.00149view →
LGGOSMedianAll0.7230.901<.00148view →
THCADFSMedianAll0.9020.754<.00144view →
OVDFSMedianIII,IV0.3280.408.01036view →
LIHCOSTertileAll0.8480.606.00135view →
CHOLOSMedianII,III,IV0.9150.413.00628view →
ACCDFSTertileII,III,IV0.6590.283.01915view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

EPB41L4A-DT–KIRC (DFS)

Kaplan–Meier survival curve for EPB41L4A-DT RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration